MAPT and Alzheimer disease: During mild cognitive impairment and AD, the amyloid β42 (Aβ42) levels, Aβ42/Aβ40 ratio, tau, ratio of phosphorylated tau at position 181 (p-tau-181) to tau, and miR-384 levels were increased in plasma EVs and were correlated with those in CSF [48].